APA aipamena

Slichter, S. J., Bolgiano, D., Kao, K., Kickler, T. S., McFarland, J., McCullough, J., & Woodson, R. (2011). PERSISTENCE OF LYMPHOCYTOTOXIC ANTIBODIES IN PATIENTS IN THE TRIAL TO REDUCE ALLOIMMUNIZATION TO PLATELETS: IMPLICATIONS FOR USING MODIFIED BLOOD PRODUCTS.

Chicago Style aipamena

Slichter, Sherrill J., Douglas Bolgiano, Kuo-Jang Kao, Thomas S. Kickler, Janice McFarland, Jeffrey McCullough, and Robert Woodson. PERSISTENCE OF LYMPHOCYTOTOXIC ANTIBODIES IN PATIENTS IN THE TRIAL TO REDUCE ALLOIMMUNIZATION TO PLATELETS: IMPLICATIONS FOR USING MODIFIED BLOOD PRODUCTS. 2011.

MLA aipamena

Slichter, Sherrill J., et al. PERSISTENCE OF LYMPHOCYTOTOXIC ANTIBODIES IN PATIENTS IN THE TRIAL TO REDUCE ALLOIMMUNIZATION TO PLATELETS: IMPLICATIONS FOR USING MODIFIED BLOOD PRODUCTS. 2011.